Sexual Health
Bexsero, Meningococcal B Vaccine, May Protect Against Gonorrhea, Study Finds
Gonorrhea is the second most common sexually transmitted disease (STD) in the United States. According to the CDC, a total of 555,608 cases of gonorrhea were reported in 2017 …CDC Report: Number of Babies Born with Syphilis Reaches 20-Year High
Syphilis is a common sexually transmitted disease (STD) spread through vaginal, anal, and oral sex. This highly contagious disease develops in stages that carry a wide array of symptoms. …Male Enhancement Facts: Benefits, Best Options, Effectiveness and Risks
Male enhancement is a thing of particular interest to men who are having issues in their sexual lives. Such issues tend to be more common as males get older …A Comprehensive Look at STDs and Their Various Types
No one can deny the fact that STDs and STIs are one of the most prevalent diseases in the world today. With an estimate of 2,295,739 cases reported in …Researchers to Start Testing Male Contraceptive Gel
Male Contraception Options There is little that men can do when it comes to birth control. They either use a condom or undergo some surgical procedure that keeps them …Study Reveals Hundreds of Supplements Contained Dangerous Compounds
Dietary supplements are typically assumed to contain natural ingredients and, so, are safe to use. But new research has revealed that many of these actually contained unapproved, possibly dangerous …New Antibody Therapy Shows Potential for HIV Control in Clinical Trials
Research coming out of Rockefeller University indicates that two HIV-fighting antibodies, when combined, can help to suppress the dreaded virus for months, possibly with less reliance on daily drug …The FDA Approves Gardasil For Men And Women Aged 27 To 45 Years Old
The FDA approved the expanded use of GARDASIL-9: a recombinant vaccine, against nine types of Human papillomaviruses for men and women aged 27 to 45 years on the 5th …Gilead’s Hepatitis C Treatment Is Now More Affordable
Gilead HCV Treatment News It was reported by officials of Gilead Sciences, Inc. in a recent press release that they were going to create a new subsidiary, Asequa Therapeutics …Posts navigation
Gilmore Health News uses cookies to improve your experience and to deliver the best possible browsing experience. For additional details, refer to the Gilmore Health Privacy Policy. By entering our site you are agreeing to our terms! Accept Privacy Policy
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.